Navigation Links
Incisive Surgical Announces Breakthrough Peer Review Clinical Study
Date:1/17/2012

MINNEAPOLIS, Jan. 17, 2012 /PRNewswire/ -- Incisive Surgical, Inc. today announced a peer-reviewed publication of a profound clinical study. The study, titled "Skin Closure With Subcuticular Absorbable Staples After Cesarean Section Is Associated With Decreased Analgesic Use," was published online by the Archives of Gynecology & Obstetrics Journal in October 2011. The authors, Drs. Joshua Nitsche (Mayo Clinic College of Medicine, Rochester, MN) and Thomas Howe (District One Hospital, Fairbault, MN), concluded that "our results suggest that the use of subcuticular absorbable staples for skin closure at the time of cesarean section may lead to less in-hospital analgesic use … are associated with less pain immediately post-operatively when pain can be the most difficult to control… [and] would result in a cost savings of approximately $200 per patient even after considering the higher cost of the absorbable staple device." The unique INSORB Absorbable Skin Stapling Technology is a revolutionary new skin closure technology that places an absorbable staple entirely underneath the skin to close surgical incisions. Patients now have a more comfortable, convenient and cosmetic choice for rapid skin closure. This unique device has won several national awards, including the 2006 Wall Street Journal Technology Innovation of the Year Award for medical devices. Incisive Surgical is the only company in the world that offers this technology and has sold over 750,000 INSORB® Absorbable Skin Staplers since the product launch in January 2005.

"The results of this peer-review clinical study are profound," said John L. Shannon, Jr., president and chief executive officer of Incisive Surgical. "The INSORB Staple does not pierce and puncture the outside of the patient's skin like metal skin staples, and this study suggests that the INSORB Skin Closure Technology may lead to higher patient satisfaction with reduced costs."

In addition, the Company announced that the U.S. Patent and Trademark Office (USPTO) issued the Company two additional key patents for its proprietary INSORB® Absorbable Skin Stapling Technology during the fourth quarter of 2011. The allowed claims for these two patents include comprehensive subject matter covering the method and apparatus of the INSORB Skin Closure technology, as well as the design of the absorbable staple. The Company holds nine INSORB Patents – seven in the United States and two in Japan – with two patents pending in Europe.

The INSORB Absorbable Skin Stapler offers the speed of metal skin staplers with the cosmetic results and comfort of absorbable sutures. The INSORB Stapler uses bioabsorbable staples that are placed underneath the skin and dissolve in the body within a matter of months. The staples, which are comprised of the same material as the leading bioabsorbable sutures, break down naturally, thereby eliminating the anxiety, pain, cost and inconvenience of post-operative staple removal.

About Incisive Surgical

Incisive Surgical, Inc. is a privately-held medical device company established to develop innovative cost-effective patient-centric solutions for skin closure. For more information or to request a media kit, contact info@insorb.com or visit www.insorb.com. To learn more about skin closure options and patients' rights, visit www.ihatemetalskinstaples.com.

John L. Shannon Jr.
952-591-2543, ext. 18
shannon@insorb.com

 

 

 

 


'/>"/>
SOURCE Incisive Surgical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Incisive Surgical Issued Notice of Allowance for Key Absorbable Skin Stapler Patent
2. Incisive Surgical Launches New National Patient Advocacy Campaign -- Eliminate Traumatic Metal Skin Staples for Routine Skin Closure
3. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
4. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
5. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
6. New Non-Surgical Stem-Cell Procedure to Relieve Chronic Tendon Problems
7. Ceremeds OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
8. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
9. Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
10. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
11. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... 2017  Faruqi & Faruqi, LLP, a leading national securities ... "Company") (NASDAQ: KMPH ) of the federal securities ... and directors and underwriters of the Company,s April 16, 2015 ... lead plaintiff. The lawsuit has been filed in ... Johnson County on behalf of all those ...
(Date:1/20/2017)... Research and Markets has announced the addition of ... OTC Amplifiers, Diagnostic Instruments), Sales Volume, Company Analysis and Forecast ... ... Sales Volume, Company Analysis and Forecast to 2022 provides a ... The growing prevalence of hearing impairment coupled with an ...
(Date:1/20/2017)... 20, 2017 Stock-Callers.com today evaluates the ... SGYP ), Novo Nordisk A/S (NYSE: NVO ), ... Therapeutics Holdings Inc. (NASDAQ: PTX ). These stocks ... 19 th , 2017, finishing near its session lows. As ... over 0.7%, while shares of health care companies in the ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... January 20, 2017 , ... A new partnership between Goodwill® and ... longer use or need, from clothes to couches to dressers and bicycles. Roadie — ... them to the nearest Goodwill donation center through February 28th. , “January is ...
(Date:1/20/2017)... , ... January 20, 2017 , ... Doctor C LLC, ... attended the January ECRM trade show to continue the marketing and distribution of its ... supplement, known for providing 400 percent better absorption than traditional vitamin C supplements. At ...
(Date:1/20/2017)... ... January 20, 2017 , ... ... enhance people’s everyday lives, recently attended the January ECRM Trade Show in Hilton ... is known for its large range of supplements that keep the body functioning ...
(Date:1/20/2017)... ... January 20, 2017 , ... "TransFlare 4K Mystique comes ... of Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Utilizing the Dragon Sensor,TransFlare 4K Mystique lens flare and light leak transitions have a ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming ... set out for each of his children. “The Angel” is the creation of published ... in New York City, and impassioned writer. , When asked of her new book, ...
Breaking Medicine News(10 mins):